Insurance - Brokers
Compare Stocks
5 / 10Stock Comparison
BWIN vs BRO vs AJG vs RYAN vs MMC
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Brokers
Insurance - Brokers
Insurance - Specialty
Insurance - Brokers
BWIN vs BRO vs AJG vs RYAN vs MMC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Brokers | Insurance - Brokers | Insurance - Brokers | Insurance - Specialty | Insurance - Brokers |
| Market Cap | $1.57B | $19.77B | $51.91B | $4.11B | $85.27B |
| Revenue (TTM) | $1.62B | $6.42B | $13.94B | $3.16B | $26.45B |
| Net Income (TTM) | $-45M | $1.15B | $1.49B | $132M | $4.13B |
| Gross Margin | 24.2% | 59.4% | 54.8% | 69.4% | 42.3% |
| Operating Margin | -4.1% | 26.8% | 18.3% | 16.6% | 23.2% |
| Forward P/E | 10.1x | 12.8x | 15.3x | 14.9x | 16.9x |
| Total Debt | $1.77B | $7.92B | $14.00B | $3.53B | $21.86B |
| Cash & Equiv. | $124M | $1.08B | $1.40B | $158M | $2.40B |
BWIN vs BRO vs AJG vs RYAN vs MMC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 24 | May 26 | Return |
|---|---|---|---|
| The Baldwin Insuran… (BWIN) | 100 | 59.9 | -40.1% |
| Brown & Brown, Inc. (BRO) | 100 | 63.1 | -36.9% |
| Arthur J. Gallagher… (AJG) | 100 | 78.5 | -21.5% |
| Ryan Specialty Hold… (RYAN) | 100 | 56.4 | -43.6% |
| Marsh & McLennan Co… (MMC) | 100 | 90.7 | -9.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BWIN vs BRO vs AJG vs RYAN vs MMC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BWIN ranks third and is worth considering specifically for value.
- Lower P/E (10.1x vs 15.3x)
BRO carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 26.6%, EPS growth -8.7%, 3Y rev CAGR 18.7%
- Lower volatility, beta 0.07, Low D/E 63.0%, current ratio 1.04x
- 26.6% revenue growth vs MMC's 7.6%
- Combined ratio 0.7 vs BWIN's 0.9 (lower = better underwriting)
AJG is the clearest fit if your priority is long-term compounding.
- 372.4% 10Y total return vs MMC's 209.8%
Among these 5 stocks, RYAN doesn't own a clear edge in any measured category.
MMC is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 19 yrs, beta 0.14, yield 1.8%
- PEG 0.88 vs AJG's 2.35
- Beta 0.14, yield 1.8%, current ratio 1.13x
- 1.8% yield, 19-year raise streak, vs BRO's 1.1%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 26.6% revenue growth vs MMC's 7.6% | |
| Value | Lower P/E (10.1x vs 15.3x) | |
| Quality / Margins | Combined ratio 0.7 vs BWIN's 0.9 (lower = better underwriting) | |
| Stability / Safety | Beta 0.07 vs BWIN's 0.52, lower leverage | |
| Dividends | 1.8% yield, 19-year raise streak, vs BRO's 1.1%, (1 stock pays no dividend) | |
| Momentum (1Y) | -22.0% vs RYAN's -54.6% | |
| Efficiency (ROA) | 7.0% ROA vs BWIN's -1.0%, ROIC 15.2% vs 3.1% |
BWIN vs BRO vs AJG vs RYAN vs MMC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BWIN vs BRO vs AJG vs RYAN vs MMC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MMC leads in 2 of 6 categories
BRO leads 1 • BWIN leads 1 • AJG leads 0 • RYAN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BRO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MMC is the larger business by revenue, generating $26.5B annually — 16.4x BWIN's $1.6B. BRO is the more profitable business, keeping 17.9% of every revenue dollar as net income compared to BWIN's -2.8%. On growth, BRO holds the edge at +37.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.6B | $6.4B | $13.9B | $3.2B | $26.5B |
| EBITDAEarnings before interest/tax | $91M | $2.1B | $3.7B | $743M | $7.0B |
| Net IncomeAfter-tax profit | -$45M | $1.1B | $1.5B | $132M | $4.1B |
| Free Cash FlowCash after capex | -$15M | $1.5B | $1.8B | $555M | $5.1B |
| Gross MarginGross profit ÷ Revenue | +24.2% | +59.4% | +54.8% | +69.4% | +42.3% |
| Operating MarginEBIT ÷ Revenue | -4.1% | +26.8% | +18.3% | +16.6% | +23.2% |
| Net MarginNet income ÷ Revenue | -2.8% | +17.9% | +10.7% | +4.2% | +15.6% |
| FCF MarginFCF ÷ Revenue | -0.9% | +23.0% | +12.8% | +17.6% | +19.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +29.4% | +37.3% | +33.6% | +15.2% | +11.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -90.0% | +9.6% | -48.2% | +2.4% | 0.0% |
Valuation Metrics
BWIN leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 18.4x trailing earnings, BRO trades at a 73% valuation discount to RYAN's 67.5x P/E. Adjusting for growth (PEG ratio), MMC offers better value at 1.11x vs AJG's 5.42x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.6B | $19.8B | $51.9B | $4.1B | $85.3B |
| Enterprise ValueMkt cap + debt − cash | $3.2B | $26.6B | $64.5B | $7.5B | $104.7B |
| Trailing P/EPrice ÷ TTM EPS | -41.96x | 18.38x | 35.11x | 67.49x | 21.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.06x | 12.83x | 15.26x | 14.90x | 16.89x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.38x | 5.42x | — | 1.11x |
| EV / EBITDAEnterprise value multiple | 13.57x | 12.91x | 17.57x | 8.20x | 15.96x |
| Price / SalesMarket cap ÷ Revenue | 1.04x | 3.32x | 3.72x | 1.35x | 3.49x |
| Price / BookPrice ÷ Book value/share | 1.31x | 1.45x | 2.25x | 7.04x | 6.38x |
| Price / FCFMarket cap ÷ FCF | — | 14.31x | 29.08x | 7.14x | 21.39x |
Profitability & Efficiency
MMC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MMC delivers a 26.9% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-4 for BWIN. AJG carries lower financial leverage with a 0.60x debt-to-equity ratio, signaling a more conservative balance sheet compared to RYAN's 2.82x. On the Piotroski fundamental quality scale (0–9), AJG scores 6/9 vs BRO's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.8% | +9.3% | +6.5% | +10.8% | +26.9% |
| ROA (TTM)Return on assets | -1.0% | +4.0% | +2.0% | +1.3% | +7.0% |
| ROICReturn on invested capital | +3.1% | +8.7% | +7.0% | +10.8% | +15.2% |
| ROCEReturn on capital employed | +4.1% | +10.3% | +7.0% | +6.4% | +17.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.63x | 0.63x | 0.60x | 2.82x | 1.62x |
| Net DebtTotal debt minus cash | $1.6B | $6.8B | $12.6B | $3.4B | $19.5B |
| Cash & Equiv.Liquid assets | $124M | $1.1B | $1.4B | $158M | $2.4B |
| Total DebtShort + long-term debt | $1.8B | $7.9B | $14.0B | $3.5B | $21.9B |
| Interest CoverageEBIT ÷ Interest expense | -1.36x | 6.88x | 3.97x | 2.29x | 6.66x |
Total Returns (Dividends Reinvested)
MMC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AJG five years ago would be worth $14,109 today (with dividends reinvested), compared to $6,977 for BWIN. Over the past 12 months, MMC leads with a -22.0% total return vs RYAN's -54.6%. The 3-year compound annual growth rate (CAGR) favors MMC at 0.7% vs BWIN's -11.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -11.8% | -25.0% | -20.9% | -37.1% | -3.6% |
| 1-Year ReturnPast 12 months | -46.5% | -47.2% | -39.8% | -54.6% | -22.0% |
| 3-Year ReturnCumulative with dividends | -30.2% | -9.3% | -2.8% | -23.8% | +2.0% |
| 5-Year ReturnCumulative with dividends | -30.2% | +12.8% | +41.1% | +20.0% | +36.5% |
| 10-Year ReturnCumulative with dividends | -30.2% | +253.0% | +372.4% | +20.0% | +209.8% |
| CAGR (3Y)Annualised 3-year return | -11.3% | -3.2% | -1.0% | -8.6% | +0.7% |
Risk & Volatility
Evenly matched — BRO and MMC each lead in 1 of 2 comparable metrics.
Risk & Volatility
BRO is the less volatile stock with a 0.07 beta — it tends to amplify market swings less than BWIN's 0.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MMC currently trades 73.8% from its 52-week high vs RYAN's 43.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.44x | 0.02x | 0.09x | 0.19x | 0.12x |
| 52-Week HighHighest price in past year | $45.16 | $113.84 | $351.23 | $72.50 | $235.78 |
| 52-Week LowLowest price in past year | $15.88 | $56.46 | $194.15 | $29.28 | $170.37 |
| % of 52W HighCurrent price vs 52-week peak | +46.5% | +51.0% | +57.5% | +43.8% | +73.8% |
| RSI (14)Momentum oscillator 0–100 | 35.8 | 24.0 | 27.8 | 28.8 | 37.2 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 3.0M | 1.9M | 2.1M | 2.7M |
Analyst Outlook
Evenly matched — BRO and MMC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BWIN as "Buy", BRO as "Hold", AJG as "Buy", RYAN as "Buy", MMC as "Hold". Consensus price targets imply 52.4% upside for BRO (target: $89) vs 18.8% for MMC (target: $207). For income investors, MMC offers the higher dividend yield at 1.75% vs RYAN's 0.71%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $28.75 | $88.50 | $274.38 | $45.60 | $206.75 |
| # AnalystsCovering analysts | 9 | 30 | 29 | 19 | 26 |
| Dividend YieldAnnual dividend ÷ price | — | +1.1% | +1.3% | +0.7% | +1.8% |
| Dividend StreakConsecutive years of raises | 0 | 27 | 12 | 0 | 19 |
| Dividend / ShareAnnual DPS | — | $0.62 | $2.56 | $0.22 | $3.05 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.5% | 0.0% | +0.1% | +1.1% |
MMC leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). BRO leads in 1 (Income & Cash Flow). 2 tied.
BWIN vs BRO vs AJG vs RYAN vs MMC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BWIN or BRO or AJG or RYAN or MMC a better buy right now?
For growth investors, Brown & Brown, Inc.
(BRO) is the stronger pick with 26. 6% revenue growth year-over-year, versus 7. 6% for Marsh & McLennan Companies, Inc. (MMC). Brown & Brown, Inc. (BRO) offers the better valuation at 18. 4x trailing P/E (12. 8x forward), making it the more compelling value choice. Analysts rate The Baldwin Insurance Group, Inc. (BWIN) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BWIN or BRO or AJG or RYAN or MMC?
On trailing P/E, Brown & Brown, Inc.
(BRO) is the cheapest at 18. 4x versus Ryan Specialty Holdings, Inc. at 67. 5x. On forward P/E, The Baldwin Insurance Group, Inc. is actually cheaper at 10. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Marsh & McLennan Companies, Inc. wins at 0. 88x versus Arthur J. Gallagher & Co. 's 2. 35x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BWIN or BRO or AJG or RYAN or MMC?
Over the past 5 years, Arthur J.
Gallagher & Co. (AJG) delivered a total return of +41. 1%, compared to -30. 2% for The Baldwin Insurance Group, Inc. (BWIN). Over 10 years, the gap is even starker: AJG returned +372. 4% versus BWIN's -32. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BWIN or BRO or AJG or RYAN or MMC?
By beta (market sensitivity over 5 years), Brown & Brown, Inc.
(BRO) is the lower-risk stock at 0. 02β versus The Baldwin Insurance Group, Inc. 's 0. 44β — meaning BWIN is approximately 1721% more volatile than BRO relative to the S&P 500. On balance sheet safety, Arthur J. Gallagher & Co. (AJG) carries a lower debt/equity ratio of 60% versus 3% for Ryan Specialty Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BWIN or BRO or AJG or RYAN or MMC?
By revenue growth (latest reported year), Brown & Brown, Inc.
(BRO) is pulling ahead at 26. 6% versus 7. 6% for Marsh & McLennan Companies, Inc. (MMC). On earnings-per-share growth, the picture is similar: Marsh & McLennan Companies, Inc. grew EPS 8. 6% year-over-year, compared to -33. 8% for Ryan Specialty Holdings, Inc.. Over a 3-year CAGR, RYAN leads at 20. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BWIN or BRO or AJG or RYAN or MMC?
Brown & Brown, Inc.
(BRO) is the more profitable company, earning 17. 7% net margin versus -2. 2% for The Baldwin Insurance Group, Inc. — meaning it keeps 17. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BRO leads at 28. 5% versus 7. 3% for BWIN. At the gross margin level — before operating expenses — RYAN leads at 90. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BWIN or BRO or AJG or RYAN or MMC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Marsh & McLennan Companies, Inc. (MMC) is the more undervalued stock at a PEG of 0. 88x versus Arthur J. Gallagher & Co. 's 2. 35x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Baldwin Insurance Group, Inc. (BWIN) trades at 10. 1x forward P/E versus 16. 9x for Marsh & McLennan Companies, Inc. — 6. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BRO: 52. 4% to $88. 50.
08Which pays a better dividend — BWIN or BRO or AJG or RYAN or MMC?
In this comparison, MMC (1.
8% yield), AJG (1. 3% yield), BRO (1. 1% yield), RYAN (0. 7% yield) pay a dividend. BWIN does not pay a meaningful dividend and should not be held primarily for income.
09Is BWIN or BRO or AJG or RYAN or MMC better for a retirement portfolio?
For long-horizon retirement investors, Arthur J.
Gallagher & Co. (AJG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 09), 1. 3% yield, +372. 4% 10Y return). Both have compounded well over 10 years (AJG: +372. 4%, BWIN: -32. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BWIN and BRO and AJG and RYAN and MMC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BWIN is a small-cap quality compounder stock; BRO is a mid-cap high-growth stock; AJG is a mid-cap high-growth stock; RYAN is a small-cap high-growth stock; MMC is a mid-cap quality compounder stock. BRO, AJG, RYAN, MMC pay a dividend while BWIN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.